검색 상세

Nonclinical Pharmacokinetics of OLX702A-075-16, N-Acetylgalactosamine Conjugated Asymmetric Small Interfering RNA (GalNAc-asiRNA)

목차

I. Introduction 1
II. Materials and methods 5
A. Chemicals and Reagents 5
B. Preparation of GalNAc-asiRNA 5
C. Quantification of OLX702A-075-16 in Plasma, Urine and Tissue Samples 7
D. LC-HRMS based Metabolite Profiling of OLX702A-075-16 in Biological Matrices 9
E. In vitro Blood-to-Plasma Ratio 10
F. In vitro Plasma Protein Binding 11
G. Nonclinical In vivo Pharmacokinetic Studies 12
H. Model Regression 14
I. Pharmacokinetic Analysis 14
III. Results 16
A. Bioanalytical method qualification 16
B. In vitro assessment 28
C. Absorption and Distribution of OLX702A-075-16 in Mice 38
D. Absorption and Distribution of OLX702A-075-16 in Rats 41
E. OLX702A-075-16 Metabolism in Mice and Rats 48
F. Renal Excretion in Rats 59
G. Comparison of plasma pharmacokinetics of OLX702A-075-16 to other GalNAc-siRNAs 61
IV. Discussion 64
V. Conclusion 70
VI. Reference 71

more